The intent of the Systemic Anti-Cancer Therapy Drug Regimen.
National Codes:
| A | Adjuvant (Retired 1 September 2019 ) |
| N | Neoadjuvant (Retired 1 September 2019 ) |
| C | Curative (Retired 1 September 2019 ) |
| P | Palliative (Retired 1 September 2019 ) |
| D | Disease Modification (Retired 1 September 2019 ) |
| 01 | Curative - aiming to permanently eradicate disease |
| 02 | Palliative - aiming to extend life expectancy |
| 03 | Palliative - aiming to relieve and/or control malignancy related symptoms |
| 04 | Palliative - aiming to achieve remission |
| 05 | Palliative - aiming to delay tumour progression |
| 98 | Other (not listed) |
This attribute is also known by these names:
| Context | Alias |
|---|---|
| formerly | DRUG TREATMENT INTENT |
| plural | SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN TREATMENT INTENTS |
